Cost-effectiveness of peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin as initial treatment of chronic hepatitis C in Belgium
| Journal | Volume 65 - 2002 |
| Issue | Fasc.2 - Symposium |
| Author(s) | J. B. Wong, F. Nevens |
| Full article |
 VIEW FREE PDF |
| (1) Division of Clinical Decision Making, Department of Medicine, Tupper Research Institute, Tufts-New England Medical Center, Tufts University School of Medicine, Boston, MA, USA ; (2) Department of Medicine, Division of Hepatology, Catholic University Hospitals, Leuven, Belgium. |
|
Initial therapy with peginterferon alfa-2b and rib- avirin results in a higher sustained virological response but is more expensive than interferon alfa-2b and rib- avirin. The objective of the analysis was to examine the cost- effectiveness of peginterferon alfa-2b combination therapy versus interferon alfa-2b combination therapy for treatment naïve chronic hepatitis C patients in Belgium. |
|
© Acta Gastro-Enterologica Belgica. |